Investing
1488 Articles
The Dogs of the Dow aren’t necessarily the worst performers of the prior year, but they pay the highest the…
For the December 14 period, short interest in financial stocks sky-rocketed compared to figures on November 30. Shares sold short…
Since it is year-end, we wanted to compile a list of the 2008 likely Dogs of the Dow. We included…
According to Reuters, Oracle (ORCL) posted strong earnings and offered a robust outlook for its business. Reuters writes that Barclays…
Early this week we are running a list of stocks that have been in a turnaround plan, yet the stocks…
Biogen-Iden (NASDAQ:BIIB) is seeing its shares pummeled in after-hours trading. The company didn’t have another biotech drug crisis though. Biogen…
It is always interesting seeing which groups and which stocks saw the biggest changes in short interest. This list doesn’t…
According to Reuters, the Fed’s decision to make an October rate cute was a "close call." Reuters writes that Paulson…
Pfizer (NYSE:PFE) is seeing additional pressure this afternoon. Apparently the FDA said it is looking into reports that Pfizer has…
According to Reuters, Goldman Sachs (GS) issued a report saying the housing sector had much further to fall and that…
We have already noted the Van der Moolen (NYSE:VDM) exit of all NYSE Specialist activities and we’ve already covered some…
Pfizer (PFE) has a new ad campaign for its erectile dysfunction drug Viagra. The marketing message is all over TV…
Following is the short interest in stocks of major companies traded on the NYSE. Figures are as of October 15…
IMS Health (RX) Bad numbers and a downgrade. Falls to $21.20 from 52-week high of $33.12. The PMI Group (PMI)…
Nektar Therapeutics (NASDAQ:NKTR) is seeing shares hitting 52-week lows after its pharmaceutical partner Pfizer Inc. (NYSE:PFE) unexpectedly said it would…
Our top personal finance-related articles today. Your wallet will thank you later.